Anaphylaxis: Office Management and Prevention

Immunology and Allergy Clinics of North America - Tập 27 - Trang 177-191 - 2007
Matthew L. Oswalt1, Stephen F. Kemp1
1Departments of Medicine and Pediatrics, The University of Mississippi Medical Center, 768 Lakeland Drive, Building LJ, Jackson, MS 39216, USA

Tài liệu tham khảo

Kemp, 2002, Anaphylaxis: a review of causes and mechanisms, J Allergy Clin Immunol, 110, 341, 10.1067/mai.2002.126811

Yocum, 1999, Epidemiology of anaphylaxis in Olmsted County: a population-based study, J Allergy Clin Immunol, 104, 452, 10.1016/S0091-6749(99)70392-1

Neugat, 2001, Anaphylaxis in the United States: an investigation into its epidemiology, Arch Intern Med, 161, 15, 10.1001/archinte.161.1.15

Simons, 2001, Epinephrine dispensing for the out-of-hospital treatment of anaphylaxis in infants and children: a population-based study, Ann Allergy Asthma Immunol, 86, 622, 10.1016/S1081-1206(10)62289-2

Simons, 2002, Epinephrine-dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis, J Allergy Clin Immunol, 110, 647, 10.1067/mai.2002.127860

Pumphrey, 2004, Anaphylaxis: can we tell who is at risk of a fatal reaction?, Curr Opin Allergy Clin Immunol, 4, 285, 10.1097/01.all.0000136762.89313.0b

Fisher, 1989, Clinical observations on the pathophysiology and implications for treatment, 309, 10.1007/978-3-642-83737-1_37

Fisher, 1986, Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse, Anaesth Intensive Care, 14, 17, 10.1177/0310057X8601400105

Kovanen, 1995, Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction, Circulation, 92, 1084, 10.1161/01.CIR.92.5.1084

Steffel, 2005, Histamine induces tissue factor expression: implications for acute coronary syndromes, Circulation, 112, 341, 10.1161/CIRCULATIONAHA.105.553735

Brazil, 1998, Not so immediate hypersensitivity: the danger of biphasic anaphylactic reactions, J Accid Emerg Med, 15, 252, 10.1136/emj.15.4.252

Stark, 1986, Biphasic and protracted anaphylaxis, J Allergy Clin Immunol, 78, 76, 10.1016/0091-6749(86)90117-X

Sampson, 1992, Fatal and near-fatal food anaphylaxis reactions in children, N Engl J Med, 327, 380, 10.1056/NEJM199208063270603

LaRoche, 1991, Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase, Anesthesiology, 75, 945, 10.1097/00000542-199112000-00004

Brown, 2004, Insect sting anaphylaxis: prospective evaluation of treatment with intravenous adrenaline and volume resuscitation, Emerg Med J, 21, 149, 10.1136/emj.2003.009449

Smith, 1980, Physiologic manifestations of human anaphylaxis, J Clin Invest, 66, 1072, 10.1172/JCI109936

Lieberman, 2005, Joint task force on practice parameters. The diagnosis and management of anaphylaxis: an updated practice parameter, J Allergy Clin Immunol, 115, S483, 10.1016/j.jaci.2005.01.010

Project Team of the Resuscitation Council (UK), 1999, Emergency medical treatment of anaphylactic reactions, J Accid Emerg Med, 16, 243, 10.1136/emj.16.4.243

Soar, 2005, European Resuscitation Council guidelines for resuscitation 2005. Section 7. Cardiac arrest in special circumstances, Resuscitation, 67, S135, 10.1016/j.resuscitation.2005.10.004

Gompels, 2002, Proposed use of adrenaline (epinephrine) in anaphylaxis and related conditions: a study of senior house officers starting accident and emergency posts, Postgrad Med J, 78, 416, 10.1136/pmj.78.921.416

Board of Directors. American Academy of Allergy and Immunology, 1994, Guidelines to minimize the risk from systemic reactions caused by immunotherapy with allergenic extracts [position statement], J Allergy Clin Immunol, 93, 811, 10.1016/0091-6749(94)90265-8

WHO Position Paper, 1998, Allergen immunotherapy. Allergen immunotherapy: therapeutic vaccines for allergic diseases, Allergy, 53, S1, 10.1111/j.1398-9995.1998.tb04930.x

Caroline, 1983

Pumphrey, 2003, Fatal posture in anaphylactic shock, J Allergy Clin Immunol, 112, 451, 10.1067/mai.2003.1614

AAAAI Board of Directors, 1994, The use of epinephrine in the treatment of anaphylaxis, J Allergy Clin Immunol, 94, 666, 10.1016/0091-6749(94)90172-4

Simons, 1998, Epinephrine absorption in children with a history of anaphylaxis, J Allergy Clin Immunol, 101, 33, 10.1016/S0091-6749(98)70190-3

Simons, 2001, Epinephrine absorption in adults: intramuscular versus subcutaneous injection, J Allergy Clin Immunol, 108, 871, 10.1067/mai.2001.119409

Barach, 1984, Epinephrine for treatment of anaphylactic shock, JAMA, 251, 2118, 10.1001/jama.251.16.2118

Lieberman, 2003, Use of epinephrine in the treatment of anaphylaxis, Curr Opin Allergy Clin Immunol, 3, 313, 10.1097/00130832-200308000-00013

Lang, 1995, Anaphylactoid and anaphylactic reactions. Hazards of B blockers, Drug Saf, 12, 299, 10.2165/00002018-199512050-00002

Toogood, 1988, Risks of anaphylaxis in patients receiving beta blocker drugs, J Allergy Clin Immunol, 81, 1, 10.1016/0091-6749(88)90212-6

Sherman, 1988, A bronchodilator action of glucagon, J Allergy Clin Immunol, 81, 908, 10.1016/0091-6749(88)90949-9

Thomas, 2005, Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta blockers, Emerg Med J, 22, 272, 10.1136/emj.2005.023507